CAMP
Basic information
Region (hg38): 3:48223347-48225491
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAMP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 2 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 1 | 1 | 2 |
Variants in CAMP
This is a list of pathogenic ClinVar variants found in the CAMP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-48223630-T-C | not specified | Uncertain significance (Jul 19, 2022) | ||
3-48224434-A-G | Benign (Apr 03, 2018) | |||
3-48224637-ACCAGGCC-A | Likely benign (Jul 04, 2018) | |||
3-48225345-A-G | Benign (Aug 14, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CAMP | protein_coding | protein_coding | ENST00000296435 | 4 | 2145 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00439 | 0.686 | 125718 | 0 | 24 | 125742 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.162 | 98 | 103 | 0.955 | 0.00000592 | 1129 |
Missense in Polyphen | 29 | 31.623 | 0.91706 | 369 | ||
Synonymous | -0.0722 | 41 | 40.4 | 1.01 | 0.00000215 | 349 |
Loss of Function | 0.654 | 4 | 5.68 | 0.704 | 2.41e-7 | 65 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000242 | 0.000242 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000897 | 0.0000879 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to bacterial lipopolysaccharides (LPS), has antibacterial activity. {ECO:0000269|PubMed:16637646, ECO:0000269|PubMed:18818205}.;
- Pathway
- NOD-like receptor signaling pathway - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Salivary secretion - Homo sapiens (human);Sterol Regulatory Element-Binding Proteins (SREBP) signalling;Integrated Lung Cancer Pathway;Vitamin D Receptor Pathway;Neutrophil degranulation;Antimicrobial peptides;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.175
Intolerance Scores
- loftool
- rvis_EVS
- 0.1
- rvis_percentile_EVS
- 61.49
Haploinsufficiency Scores
- pHI
- 0.225
- hipred
- N
- hipred_score
- 0.276
- ghis
- 0.385
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.691
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Camp
- Phenotype
- cellular phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- innate immune response in mucosa;antimicrobial humoral response;antibacterial humoral response;defense response to bacterium;neutrophil degranulation;negative regulation of growth of symbiont on or near host surface;innate immune response;defense response to Gram-negative bacterium;defense response to Gram-positive bacterium;killing by host of symbiont cells;antimicrobial humoral immune response mediated by antimicrobial peptide
- Cellular component
- extracellular region;extracellular space;specific granule lumen;specific granule;extracellular exosome;tertiary granule lumen
- Molecular function
- lipopolysaccharide binding